Science

Psilocybin receives [Non-Profit] ‘breakthrough therapy’ designation from the FDA

“What is truly groundbreaking is FDA’s rightful acknowledgement that MDD (Major Depressive Disorder], not just the much smaller treatment-resistant depression population, represents an unmet medical need and that the available data suggest that psilocybin may offer a substantial clinical improvement over existing therapies.” -Dr. Charles Raison, MD

Compass Pathways, a pharmaceutical research firm, received the designation for studying psilocybin as a treatment for treatment-resistant depression.

Original Article (Business Wire):
FDA grants breakthrough therapy designation to Usona Institute’s psilocybin program for major depressive disorder
Artwork Fair Use: Non profit organization lawyers oakland

Psychology

Home grow…

Psychology

…for macrodosing

Politics

First, it was weed…

Politics

Manufacturing…

Spirituality

…the Mushroom

Politics

Oregon psilocybin…

Science

What is kratom…?

Politics

SITSA … stopped

Politics

Grassy Globes

Politics

Weed wages water war

Politics

Big acid

Politics

Can Kratom be patented?

Science

Kratom LD-50 Stats

Science

Rolling in the deep

Science

The Peace Drug